SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

GLP-1 is a hormone that regulates blood sugar, appetite and digestion. A diet rich in high-fiber foods may help your body ...

For people beginning their weight loss journey, a combination of physical activity and a healthy diet – such as the ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

Researchers conducted the REDEFINE 1 and REDEFINE 2 clinical trials to assess the effect of CagriSema on weight loss in obesity with or without type 2 diabetes.

Nurse practitioners form the key to providing culturally competent care, which improves outcomes for Asian American patients.

SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

"Nordic Cold Chain launches cold chain packaging for GLP-1 drugs" was originally created and published by Packaging Gateway, ...